$77.65
-3.96 (-4.85%)
At Close: Jun 25, 2026
Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04:05pm, Tuesday, 10'th Sep 2024
BRISBANE, Calif., Sept. 10, 2024 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA) today announced that on September 5, 2024, the Compensation Committee granted inducement awards consisting o
Xiao-I Corporation Regains Compliance with Nasdaq Listing Rules
09:45am, Tuesday, 10'th Sep 2024
SHANGHAI , Sept. 10, 2024 /PRNewswire/ -- Xiao-I Corporation (NASDAQ: AIXI) ("Xiao-I" or the "Company"), a leading artificial intelligence company, today announced that on September 9, 2024 it receive
Buy These 5 Nasdaq Stocks With Double-Digit Returns in the Past Month
09:31am, Tuesday, 10'th Sep 2024
Five recently thriving Nasdaq Composite-listed stocks are: AFRM, ACGL, COO, ERIE, WDAY.
Sunrise Regains Compliance with Nasdaq Minimum Closing Bid Price Rule
09:28am, Tuesday, 10'th Sep 2024
ZIBO, China, Sept. 10, 2024 (GLOBE NEWSWIRE) -- Sunrise New Energy Co., Ltd. (“Sunrise”, the “Company”, “we” or “our”) (NASDAQ: EPOW), today announced that the Company has received a f
Nasdaq to show resilience despite Apple drag
08:25am, Tuesday, 10'th Sep 2024
A tepid reaction to Apple Inc (NASDAQ:AAPL, ETR:APC)'s iPhone 16 debut is expected to cause a 0.7% fall on the world's most valuable company's share price when US markets open today. That will not be
The market sentiment seems to fluctuate as the index futures dipped slightly, indicating a lower opening on Tuesday. The CBOE Volatility, aka VIX, rose slightly but held around the 20 level.
Mountain & Co. I Acquisition Corp. Announces Receipt of Nasdaq Delisting Determination - Intention to Appeal
07:53pm, Monday, 09'th Sep 2024
NEW YORK , Sept. 9, 2024 /PRNewswire/ -- Mountain & Co. I Acquisition Corp. (the "Company") announces that on September 3, 2024, the Company received a letter (the "Letter") from the NASDAQ Stock Mark
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04:45pm, Monday, 09'th Sep 2024
BEDFORD, Mass., Sept. 09, 2024 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that on September 3,
Vine Hill Capital Investment Corp. Announces Closing of $200,000,000 Initial Public Offering
04:15pm, Monday, 09'th Sep 2024
Fort Lauderdale, Florida, Sept. 09, 2024 (GLOBE NEWSWIRE) -- Vine Hill Capital Investment Corp. (the “Company”), a special purpose acquisition company, today announced the closing of its initial p
Should You Buy the 4 "Magnificent Seven" Stocks That Underperformed the S&P 500 and Nasdaq Composite in 2024?
04:20am, Monday, 09'th Sep 2024
After big gains in 2023, many of the "Magnificent Seven" stocks have cooled off in 2024. Alphabet, Amazon, Microsoft, and Tesla all lag the major indexes through the end of August.
2 Nasdaq Stocks to Buy Before They Soar as Much as 141%, According to Select Wall Street Analysts
05:02am, Sunday, 08'th Sep 2024
Despite the index notching a number of new all-time highs this year, many Wall Street analysts believe there's still upside ahead for the Nasdaq. Economic headwinds have weighed on Sirius XM, represen
Embrace Change Acquisition Corp. Receives Additional Staff Determination Notice from Nasdaq Related to Delayed Quarterly Report
11:00pm, Saturday, 07'th Sep 2024
SAN DIEGO, Sept. 07, 2024 (GLOBE NEWSWIRE) -- Embrace Change Acquisition Corp. (Nasdaq: EMCG, EMCGW, EMCGU, EMCGR) ("Embrace Change" or the "Company"), announced today that on September 5, 2024, it re
Is It Time to Buy August's Worst-Performing Nasdaq Stocks?
04:31am, Saturday, 07'th Sep 2024
Super Micro Computer tumbled on a weak earnings report, a short-seller attack, and a delay in its 10-K filing. Moderna plunged as it slashed its guidance for the year.
PORTLAND, Ore. , Sept. 6, 2024 /PRNewswire/ -- Eastside Distilling, Inc. (Nasdaq: EAST) ("Eastside" or the "Company"), a consumer-focused beverage company that builds craft inspired experiential brand
NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04:32pm, Friday, 06'th Sep 2024
NAARDEN, the Netherlands and MIAMI, Sept. 06, 2024 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or “NewAmsterdam” or the “Company”), a late-stage, clinical biopharmaceuti
Sign In
Buy NDAQ